23andMe

23andMe popularized direct-to-consumer genetic testing, building a database of over 12 million genotyped customers. The company provides ancestry and health risk information while using aggregated data for drug discovery research. 23andMe's challenges illustrate the difficulties of monetizing consumer genomics data responsibly.